Table 2.
Clinical and laboratory characteristics according to disease location in small bowel Crohn’s disease patients.
| Ileitis | Ileo-colitis | P value | |
|---|---|---|---|
| (N = 51) | (N = 170) | ||
| SES-CD, N | 51 | 112 | <0.001 |
| median (IQR) | 0 (0–4) | 5 (3–9) | |
| FC (μg/g),N | 51 | 162 | 0.148 |
| median (IQR) | 254.4 (95.4–914.6) | 584.7 (136.3–1081.6) | |
| ESR (mm/h), N | 43 | 147 | 0.001 |
| median (IQR) | 12 (6–23) | 20 (11–40) | |
| CRP (mg/L), N | 51 | 170 | 0.001 |
| median (IQR) | 4.2 (0.9–15) | 12.7 (2.0–44.0) | |
| MaRIA, N | 16 | 57 | 0.002 |
| median (IQR) | 21.53 (9.6–33.4) | 39.5 (20.9–63.3) | |
| CDAI, N | 44 | 163 | 0.052 |
| median (IQR) | 129 (83.5–184.8) | 173 (87–253) |
IQR, interquartile range; SES-CD, simple endoscopic score for Crohn’s disease; FC, faecal calprotectin; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; MaRIA, Magnetic resonance index of activity; CDAI, Crohn’s disease activity index.